Last reviewed · How we verify
Cefixime 400mg
At a glance
| Generic name | Cefixime 400mg |
|---|---|
| Also known as | supprax |
| Sponsor | Bulovka Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Azithromycin and Cefixime Treatment of Typhoid in South Asia Trial (ACT-South Asia Trial) (PHASE4)
- Cefixime Versus Benzathine Penicillin G in Treatment of Early Syphilis (PHASE4)
- Cefixime Clinical Trial (PHASE3)
- Cefixime for Alternative Syphilis Treatment (PHASE2)
- Trial Evaluating the Clinical Efficacy of Cefixime for Treatment of Early Syphilis in Non-pregnant Women (PHASE1, PHASE2)
- The Pharmacokinetics of Extended Duration High-dose Cefixime for the Decreased Susceptibility of Neisseria Gonorrhoeae: A Phase I Pilot Study (PHASE1)
- A Bioequivalence Study of SKF101804 Cefixime Versus Cefixime Reference Formulation in Healthy Adults Under Fasting Conditions (PHASE1)
- "Performance of HPV DNA Test in Presence of Co-infection With Common RTIs" (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |